Feline Toxoplasmosis: Zoonotic Risks, Clinical Signs, and Management in Cats
Introduction
Feline toxoplasmosis is a parasitic infection caused by the apicomplexan protozoan Toxoplasma gondii. Domestic cats and other felids serve as the definitive hosts, in which the parasite completes its sexual cycle and sheds environmentally resistant oocysts [1, 2]. This infection is of major veterinary and public health concern because of its zoonotic potential. The term "toxoplasmosis cat lady disease" has entered popular discourse, often conflating cat ownership with infection risk, but the epidemiological reality is far more nuanced. This article provides an exhaustive review of the biological, clinical, and diagnostic aspects of feline toxoplasmosis, with a focus on evidence-based management strategies.
Etiology and Life Cycle
Toxoplasma gondii exists in three infectious stages: tachyzoites (rapidly dividing, acute stage), bradyzoites (slowly dividing, tissue cyst stage), and sporozoites (within sporulated oocysts) [1]. Cats acquire infection primarily by ingesting tissue cysts from intermediate hosts (rodents, birds) or, less commonly, by ingesting sporulated oocysts from the environment [3, 4].
Once ingested, bradyzoites excyst in the feline small intestine and invade enterocytes, where they undergo multiple rounds of asexual replication (schizogony) followed by sexual differentiation (gametogony) [1, 2]. After fertilization, unsporulated oocysts are shed in the feces. Shedding typically begins 3 to 10 days after primary infection and can last 1 to 3 weeks, during which millions of oocysts may be excreted [5, 3]. Sporulation in the environment occurs within 1 to 5 days under appropriate conditions of temperature and humidity, rendering oocysts infectious to a wide range of warm-blooded vertebrates [6, 7].
Extraintestinal dissemination occurs when tachyzoites invade mononuclear cells and disseminate via the lymphatics and bloodstream to tissues such as skeletal muscle, myocardium, and the central nervous system [8, 9]. Under immune pressure, tachyzoites convert to bradyzoites, forming cysts that persist for the life of the host [10].
Epidemiology
Seroprevalence of T. gondii in feline populations varies widely by geographic region, management practices, and diagnostic methodology. In Hong Kong, a study found seroprevalence rates of 5.2% in privately owned cats and 10.8% in community cats [11]. In Jordan, the first molecular and serological survey reported a seroprevalence of 42.0% among stray and owned cats, with significant associations with age and outdoor access [3]. A study in Thailand detected T. gondii DNA in 4.4% of fecal samples from stray cats using PCR, underscoring the role of free-roaming populations in environmental contamination [5]. In Brazil, high seroprevalence has been reported in cats from the Pantanal region, indicating widespread exposure, particularly in areas with high densities of wildlife intermediate hosts [12].
Risk factors for seropositivity include older age, outdoor access, raw meat consumption, and living in multi-cat households or shelters [11, 3]. Climatic and ecological factors also modulate oocyst survival; soil moisture and temperate conditions facilitate sporulation and longevity of oocysts [13, 7]. A systematic review of wildlife infections in China found that felids and their prey species (e.g., rodents) are key reservoirs, maintaining the parasite in sylvatic cycles [7].
Zoonotic Risks
The feline host is central to the epidemiology of human toxoplasmosis. Cats are the only definitive host capable of shedding oocysts, which are the primary source of infection for herbivorous intermediate hosts and also a direct source for humans via accidental ingestion [13, 14]. Human infection can occur through ingestion of sporulated oocysts from contaminated soil, water, or unwashed produce, as well as through consumption of undercooked meat containing tissue cysts [15, 16]. A study in Brazil highlighted that environmental exposure in informal settlements, where cats are abundant and sanitation is poor, is significantly associated with seropositivity [13].
The term "toxoplasmosis cat lady disease" often emerges in public discourse linking cat ownership to infection risk. However, epidemiological data show that direct transmission from pet cats is relatively uncommon. Most cats shed oocysts only for a short period after primary infection and are not infectious to humans thereafter, provided standard hygiene measures are observed [14, 3]. The primary risk to humans is not from handling their own pet cat but from environmental contamination by feral or stray cats, combined with inadequate handwashing and consumption of contaminated food or water [13, 15]. This distinction is critical for veterinary professionals communicating with clients.
Serological surveys in veterinary professionals show elevated seroprevalence compared to the general population, likely due to occupational exposure to cat feces and tissues [17]. Pregnant women who are seronegative are often advised to avoid cleaning litter boxes or to use gloves and masks, though the risk is low if the cat is strictly indoor and not fed raw meat [14, 18]. A study in Côte d'Ivoire found that knowledge of toxoplasmosis transmission was poor among pregnant women, highlighting the need for targeted education [15].
Ocular toxoplasmosis is a recognized sequela in humans, often resulting from congenital infection or reactivation of latent cysts [9]. Although rare, severe cases of cerebral toxoplasmosis occur in immunocompromised individuals, including organ transplant recipients [19]. Comparative host-range parallels can be drawn with other apicomplexan parasites, but T. gondii is unique in its remarkably wide intermediate host range, encompassing virtually all warm-blooded vertebrates [6, 20].
Clinical Signs in Cats
Most immunocompetent cats infected with T. gondii remain subclinical. When clinical signs occur, they are most often seen in kittens, immunocompromised animals, or those with concurrent disease [8]. The disease can manifest as enteritis, pneumonia, hepatitis, myocarditis, or encephalomyelitis, depending on the organ system affected.
Gastrointestinal signs include anorexia, lethargy, vomiting, and diarrhea, often associated with the enteroepithelial cycle during primary infection [2, 21]. Respiratory involvement presents as dyspnea, cough, and tachypnea due to interstitial pneumonia. Ocular signs include anterior uveitis, retinitis, and chorioretinitis, which may present as photophobia, squinting, or visual deficits [9]. Neurological signs are common in severe cases and may include ataxia, circling, seizures, tremors, and altered behavior [8, 9]. Involvement of the brain and spinal cord can be detected on magnetic resonance imaging or via analysis of cerebrospinal fluid.
In cats undergoing the sexual cycle in the intestinal mucosa, there is upregulation of immune-related microRNAs, indicating local inflammatory responses [21]. Histopathological lesions in fatal cases typically reveal necrotic foci infiltrated with tachyzoites in the liver, lungs, and central nervous system [22, 8].
Diagnostics
Diagnosis of feline toxoplasmosis requires a combination of serological, molecular, and cytological methods, as clinical signs are often nonspecific.
Serology
Detection of anti-T. gondii IgG and IgM antibodies is the most common approach. Commercial ELISA kits and indirect immunofluorescent antibody tests are widely used [23, 24]. A positive IgG indicates prior exposure, while rising titers (paired samples 2 to 4 weeks apart) or presence of IgM indicates recent or active infection. A double-antigen sandwich colloidal gold immunochromatographic strip has been validated for rapid serological screening in multiple host species, providing point-of-care results with high sensitivity and specificity [23]. Similarly, a SAG1-based colloidal gold strip has been developed for swine but can be adapted for feline use [24].
Molecular Detection
PCR-based assays detect T. gondii DNA in blood, feces, cerebrospinal fluid, tissue biopsies, and aqueous humor. Conventional PCR targeting the 529 bp repetitive element offers high sensitivity as this element is present in 200 to 300 copies per genome [25]. An antisense PCR assay has shown improved specificity and sensitivity for feline samples by targeting the complement of the commonly used B1 gene transcript, reducing false negatives from degraded RNA [25]. Quantitative real-time PCR (qPCR) can measure parasite load, which is useful for monitoring treatment response.
In the context of diagnosis, a molecular algorithm is often followed:
flowchart TD
A[Cat with clinical signs suggestive of toxoplasmosis], > B{Serology}
B, >|IgG positive + IgM negative| C[Prior exposure; active infection unlikely unless rising titers]
B, >|IgM positive or rising IgG| D[Active/Recent infection suspected]
D, > E{Confirm with PCR on blood or CSF}
E, >|Positive| F[Confirmed acute toxoplasmosis]
E, >|Negative but strong clinical suspicion| G[Consider ocular fluid or tissue PCR]
G, >|Positive| F
G, >|Negative| H[Re-evaluate differential diagnoses]
B, >|Both negative| H
F, > I[Initiate antiprotozoal therapy and monitor]
Cytology and Histopathology
Impression smears or fine-needle aspirates of affected tissues (lymph nodes, lungs) may reveal tachyzoites after Giemsa staining, though sensitivity is low [10, 22]. Histopathology with immunohistochemistry using antibodies against T. gondii antigens is the gold standard for definitive diagnosis in necropsy specimens [22]. The MIC17A protein has shown promise as a specific marker for both entero-epithelial and chronic stage infection in feline tissues [10].
Treatment and Management
The goal of treatment in cats with active toxoplasmosis is to reduce the tachyzoite burden and control inflammation. The cornerstone of therapy is clindamycin, a lincosamide antibiotic that inhibits protein synthesis in apicomplexan parasites [8]. The recommended dosage is 10 to 12 mg/kg orally or intramuscularly every 12 hours for 4 weeks. Alternative regimens include trimethoprim-sulfadiazine (15 mg/kg every 12 hours) or ponazuril (5 to 10 mg/kg daily for 3 to 5 days) [9].
Corticosteroids (e.g., prednisolone at 1 mg/kg twice daily) are indicated when ocular or neurological inflammation is severe, but should only be used concurrently with antiprotozoal therapy to prevent exacerbation of infection [9]. Supportive care includes fluid therapy, nutritional support, and, in cases of respiratory distress, oxygen supplementation.
The long-term prognosis depends on the severity of organ involvement. Cats that survive the acute phase often become lifelong carriers of tissue cysts, but reactivation is rare in immunocompetent animals [8]. In immunocompromised cats (e.g., feline leukemia virus or feline immunodeficiency virus positive), chronic suppressive therapy with clindamycin may be warranted.
Control and Prevention
Preventing feline toxoplasmosis involves three key strategies: reducing exposure to infective stages, environmental decontamination, and public education.
Feeding cats only commercially processed, cooked, or frozen-thawed food eliminates the risk of ingesting tissue cysts [3, 4]. Cats should be prevented from hunting and scavenging, which requires confinement to indoors or supervised outdoor access [11]. Litter boxes should be cleaned daily, as oocysts require 1 to 5 days to sporulate and become infectious [5, 3]. Pregnant women and immunocompromised individuals should delegate litter box cleaning to others or wear disposable gloves and wash hands thoroughly [14].
The development of vaccines for cats remains an active area of research. Gene-edited live-attenuated vaccines, such as those using CRISPR-Cas9 deletion of essential virulence genes, have shown promise in inducing protective immunity in animal models [26]. Recombinant antigen and mRNA vaccine platforms are also being investigated, though no product is commercially available for cats at this time [27]. A field-validated diagnostic strip could facilitate screening in shelter populations to identify shedders and isolate them during the patent period [23].
Environmental contamination with oocysts is a major public health concern. Oocysts can survive for months in moist, shaded soil and are resistant to many disinfectants [13]. Hot water (>60°C) and steam cleaning are effective for inactivating oocysts on impermeable surfaces. In community settings, reducing the number of free-roaming cats and implementing trap-neuter-return programs can lower environmental oocyst load and reduce zoonotic risk [5, 12].
Public health messaging must be evidence-based. The concept of "toxoplasmosis cat lady disease" is a misnomer that stigmatizes cat owners without reflecting the true transmission dynamics. Most human infections are foodborne, not directly from pet cats [13, 14]. Veterinary professionals should educate clients on these distinctions while still recommending basic hygiene practices.
Cross-reference articles such as Toxoplasmosis in Cats: Zoonotic Risks and Feline Love and Feline Toxoplasmosis: Zoonotic Risk, Clinical Manifestations, and Prevention in Pregnant Women and Immunocompromised Individuals provide additional context. The reader is also directed to Toxoplasmosis in Cats: Zoonotic Risk and Public Health Implications and Toxoplasmosis in Cats: Shedding, Diagnosis, and Public Health Risks.
References
[1] Sena F, Hakimi M-A, Francia ME. Proliferating toward sex: characterization of cell division of Toxoplasma gondii's pre-sexual stages. mBio. 2026. https://pubmed.ncbi.nlm.nih.gov/42153709/
[2] Alrubaye HS, Reilly SM, da Silva R, et al. A single-cell atlas of Toxoplasma sexual development in the feline intestinal tract. Nat Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/42020723/
[3] Alkhatatbeh SK, Lafi SQ, Hammad HB, et al. The first seroprevalence and molecular detection of toxoplasmosis infecting cats in Jordan with associated risk factors. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41741047/
[4] Biswas PK, Aryal D, Tarak AN, et al. Genotype distribution and risk factors of Toxoplasma gondii infection in animals of Trishal, Bangladesh. PLoS One. 2026. https://pubmed.ncbi.nlm.nih.gov/41528989/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.
[5] Kengradomkij C, Chimnoi W, Kamyingkird K, et al. PCR detection of Toxoplasma gondii DNA in fecal samples from stray cats in Bangkok Metropolitan, Thailand. Food Waterborne Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/42094705/
[6] Andrade ACS, Vieira FPR, Dos Santos IC, et al. Nonhuman Primates and Wild Felines as Environmental Bioindicators of Toxoplasma gondii and Leishmania spp. from a Brazilian Zoo. Vector Borne Zoonotic Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/41879174/
[7] Zhu XK, Cong W, Meng QF. Toxoplasma gondii infection in wildlife in China (1985-2024): A systematic review and meta-analysis with machine learning. Prev Vet Med. 2026. https://pubmed.ncbi.nlm.nih.gov/41747478/
[8] Murata FHA, Barboza JP, de Souza CAG, et al. Investigation of Toxoplasma gondii in reproductive tissues of companion animals from a municipal neutering program. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41651631/
[9] Askaryanzardak A, Kakkassery V, Tartaglione Gracia GP, et al. [Ocular toxoplasmosis in adults : Refresher course]. Ophthalmologie. 2026. https://pubmed.ncbi.nlm.nih.gov/41603939/
[10] Günay-Esiyok Ö, Koçkaya ES, Yılmaz R, et al. The Potential of MIC17A both as an Entero-epithelial and Chronic Stage Marker for Detection of Feline Toxoplasmosis. Curr Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/41874672/
[11] Elsohaby I, Zubair M, Baqar Z, et al. Seroprevalence of Toxoplasma gondii and associated demographic factors in privately-owned dogs, cats, and community cats in Hong Kong. BMC Vet Res. 2026. https://pubmed.ncbi.nlm.nih.gov/42135800/
[12] Artiaga-Silva GL, de Lima Ruy Dias ÁF, Carvalho MR, et al. High Seroprevalence Rates of Toxoplasma gondii and Neospora caninum in Dogs in the Pantanal Region of Mato Grosso, Brazil. Acta Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/41843222/
[13] Eyre MT, Wang JY, Carneiro IO, et al. Social marginalisation, environmental degradation and Toxoplasma gondii exposure in urban informal settlements in Brazil. PLoS Negl Trop Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/42330015/
[14] Gharbi M, Yera H, Dupouy-Camet J. [The cat, the women and the toxoplasma: What advice should be given to a pregnant woman who is seronegative for toxoplasmosis and owns a cat?]. Gynecol Obstet Fertil Senol. 2026. https://pubmed.ncbi.nlm.nih.gov/41628830/
[15] Henriette BA, Jémima EK, Jean-Sébastien MA, et al. First report of knowledge and practices towards toxoplasmosis among pregnant women in primary care in Abidjan, Côte d'Ivoire. Trop Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/42199683/
[16] Orish VN, Tetteh RE, Adzah D, et al. Toxoplasma gondii seropositivity among patients with sickle cell disease: Prevalence and association with blood transfusion history. PLoS One. 2026. https://pubmed.ncbi.nlm.nih.gov/41931585/
[17] de Velasco-Reyes I, Torres-García SE, Hernández-Rangel JJ, et al. Seroprevalence of Toxoplasma gondii Infection in Veterinary Medicine Professionals and Students in Aguascalientes, Mexico. Epidemiologia (Basel). 2026. https://pubmed.ncbi.nlm.nih.gov/42201205/
[18] Karacali B, Mor N. Investigation of anti-Toxoplasma gondii antibody seropositivity and possible risk factors in women with abortion or stillbirth history in Kars, Turkey. Afr J Reprod Health. 2026. https://pubmed.ncbi.nlm.nih.gov/42202767/
[19] Mihaljević D, Sitaš Z, Hanulak J, et al. Cerebral Toxoplasmosis in a Renal Transplant Recipient-A Rare Complication. Life (Basel). 2026. https://pubmed.ncbi.nlm.nih.gov/41900989/
[20] Filho SCC, Moron SE, Ferreira RG, et al. Risk Factors and Ocular Health Associated with Toxoplasmosis in Quilombola Communities. Microorganisms. 2026. https://pubmed.ncbi.nlm.nih.gov/41597614/
[21] Zhai B, Bao B, Xie SC, et al. Dynamic landscape of microRNA expression in the feline small intestine during Toxoplasma gondii infection. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/41965856/
[22] Ait Issad N, Mohamed Cherif A, Mebkhout F, et al. First report of molecular and histopathological detection of Toxoplasma gondii in aborted fetal goat myocardium in Algeria with associated risk factors. Parasitol Int. 2026. https://pubmed.ncbi.nlm.nih.gov/41864556/
[23] Mu X, Chen C, Pu X, et al. Development and Field Validation of a Double-Antigen Sandwich Colloidal Gold Immunochromatographic Strip for Detection of Toxoplasma gondii Antibodies in Multiple Host Species. Transbound Emerg Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/42253330/
[24] Chen XX, Sun H, Liang Y, et al. Development of a SAG1-based colloidal gold immunochromatographic strip for rapid serological detection of swine Toxoplasma gondii. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/42169035/
[25] Li YY, Bai SY, Yu HQ, et al. Development and evaluation of an antisense PCR assay for Toxoplasma gondii detection in domestic cats. Vet Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/41724116/
[26] Sang X, Zhang H, Zhang Y, et al. Gene-edited live-attenuated vaccines against Toxoplasma gondii: recent advances and future frontiers. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/42252477/
[27] Qadeer A, Tharwat M, Khan MZ, et al. Advances and Translational Challenges in Toxoplasma gondii Vaccine Development: From Antigen Discovery to mRNA and One Health Strategies. Vet Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/42188907/
[28] Pinto GOA, Silva RAD, Oliveira PRF, et al. Molecular detection of Toxoplasma gondii in an aborted equine fetus and serological evidence of infection in mares enrolled in embryo transfer programs in Brazil. J Equine Vet Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/42252005/
[29] Aziz KJ, Mikaeelb FB, Nasrullah OJ, et al. Seroepidemiological investigation of Toxoplasma gondi and Neospora caninum in local Deers in Erbil, Iraq. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/42034957/
[30] Muhammad AS, Kudi AC, Mohammed A, et al. Public health significance of prevalence and risk factors associated with Toxoplasma gondii infection in goats sampled from two quarantine facilities and an institutional farm in Maiduguri metropolis, Borno state, Nigeria. Sci Rep. 2026. https://pubmed.ncbi.nlm.nih.gov/42020619/
[31] Tsakmakidis I, Moustakidis K, Alvanou MV, et al. Migratory and opportunistic wild and domestic birds, as Toxoplasma gondii carriers. Parasite Epidemiol Control. 2026. https://pubmed.ncbi.nlm.nih.gov/41970607/
[32] Chalabi KN, Jabar Bakr E. Toxoplasmosis - knowledge among university students in Erbil, Iraq: a cross-sectional study. Int J Environ Health Res. 2026. https://pubmed.ncbi.nlm.nih.gov/41873025/
[33] Hanedan B, Taş BZ, Yıldırım E, et al. Investigation of Toxoplasma gondii seroprevalence and associated risk factors in dairy cattle in the Eastern Anatolia region of Türkiye. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41819961/
[34] Marín-García PJ, Ballesteros-García O, Martínez-Sáez L, et al. Low seroprevalence of Toxoplasma gondii in pig farms (Sus scrofa domesticus) of eastern Spain in intensive farms with control of animal entry. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41741032/
[35] Jesuthasan J, Merritt K, Solmi F, et al. The association between childhood Toxoplasma gondii, psychotic experiences and grey matter volume: A population-based cohort study. Schizophr Res. 2026. https://pubmed.ncbi.nlm.nih.gov/41643571/